Trending:
October 1, 2025, 01:44 PM - 3 min read
Owners of the affected industries blame the “inspector raj” and the sudden enforcement of revised Schedule M norms, aligned with US standards, for the crisis. They argue that the compliance requirements are not practical for small and micro pharma firms to meet within the limited timeframe.
Read more